Novo Nordisk shares plunge after CagriSema obesity drug trial disappoints – ReutersRead More
Novo Nordisk shares plunge after CagriSema obesity drug trial disappoints Reuters
Related Posts
/cloudfront-us-east-2.images.arcpublishing.com/reuters/EBMVZ4LWFVIS5IDM5E62SMHZWA.jpg)
US defense chief Austin visits Kyiv as questions swirl over aid to Ukraine Reuters
U.S. Secretary of Defense Lloyd Austin arrived in Kyiv on Monday for an unannounced visit and expressed American support "for the long haul" as questions swirled over the sustainability of…
/cloudfront-us-east-2.images.arcpublishing.com/reuters/L4NIGLFBHNIRXH6U2CP3GHQC6I.jpg)
Israel presses ahead in battle against Hamas in southern Gaza Reuters
Fighting between Israel and Hamas intensified across Gaza on Monday, fuelling fears flagged by the United Nations at the weekend of a breakdown in public order and a mass exodus…
/cloudfront-us-east-2.images.arcpublishing.com/reuters/M2L43FGYYVN7FAHQRCR7FLZLIQ.jpg)
Hurricane Otis kills at least 27 hammers Acapulco as damage seen in billions Reuters Canada
Hurricane Otis claimed the lives of at least 27 people, Mexico's government said on Thursday after one of the most powerful storms to hit the country hammered the beach resort…